Allstate Corp Invests $2.20 Million in Amrize Ltd $AMRZ

Allstate Corp purchased a new position in Amrize Ltd (NYSE:AMRZ) during the fourth quarter, Holdings Channel reports. The institutional investor purchased 40,731 shares of the company’s stock, valued at approximately $2,203,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. State of Wyoming acquired a new position in shares of Amrize in the 3rd quarter worth approximately $32,000. Laurel Wealth Advisors LLC acquired a new position in shares of Amrize during the 4th quarter valued at $34,000. US Bancorp DE acquired a new position in shares of Amrize during the 3rd quarter valued at $38,000. Costello Asset Management INC acquired a new position in shares of Amrize during the 3rd quarter valued at $44,000. Finally, Jones Financial Companies Lllp acquired a new position in shares of Amrize during the 3rd quarter valued at $53,000.

Insider Activity

In other news, insider Nollaig Forrest bought 2,000 shares of Amrize stock in a transaction dated Friday, May 22nd. The stock was purchased at an average price of $50.25 per share, for a total transaction of $100,500.00. Following the purchase, the insider directly owned 20,139 shares in the company, valued at $1,011,984.75. The trade was a 11.03% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jan Philipp Jenisch bought 3,000 shares of Amrize stock in a transaction dated Tuesday, May 19th. The stock was purchased at an average price of $49.96 per share, with a total value of $149,880.00. Following the purchase, the chief executive officer owned 515,000 shares in the company, valued at approximately $25,729,400. This represents a 0.59% increase in their ownership of the stock. The SEC filing for this purchase provides additional information. In the last 90 days, insiders have bought 131,554 shares of company stock worth $7,152,069. 0.54% of the stock is owned by insiders.

Amrize Stock Performance

NYSE AMRZ opened at $52.98 on Friday. Amrize Ltd has a 1 year low of $44.12 and a 1 year high of $65.94. The company has a debt-to-equity ratio of 0.38, a current ratio of 1.40 and a quick ratio of 0.89. The firm has a market cap of $29.30 billion and a price-to-earnings ratio of 25.35. The company has a fifty day moving average price of $54.44 and a 200-day moving average price of $55.16.

Amrize (NYSE:AMRZ) last posted its earnings results on Wednesday, April 29th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.14) by ($0.02). Amrize had a return on equity of 9.84% and a net margin of 9.70%.The firm had revenue of $2.18 billion during the quarter. Amrize’s revenue for the quarter was up 4.7% on a year-over-year basis. As a group, equities research analysts predict that Amrize Ltd will post 2.76 EPS for the current fiscal year.

Amrize Cuts Dividend

The company also recently announced a dividend, which was paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th were paid a $0.11 dividend. The ex-dividend date was Tuesday, May 12th. Amrize’s dividend payout ratio is presently 21.05%.

Analyst Ratings Changes

A number of research analysts recently issued reports on the stock. Weiss Ratings downgraded shares of Amrize from a “hold (c+)” rating to a “hold (c)” rating in a research report on Monday, May 18th. JPMorgan Chase & Co. boosted their target price on shares of Amrize from $60.00 to $70.00 and gave the company an “overweight” rating in a research report on Thursday, March 5th. Stephens reiterated an “overweight” rating and set a $65.00 target price on shares of Amrize in a research report on Monday, May 18th. Vertical Research upgraded shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 target price on the stock in a research report on Friday, May 1st. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating on shares of Amrize in a research report on Monday, February 23rd. One analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $64.86.

Amrize Profile

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.